All funds

Leaven Partners

Dec 2024 → Sep 2026 · 2 funds

Our archive holds 9 letters from Leaven Partners, behind 3 investment theses and positions in 5 companies. Every quote below is copied verbatim from the letter it came from.

Get an email when this fund publishes its next letter

9
Letters
5
Companies
2
Moves
3
Theses

Performance

as of Jun 30, 2026 · gross of fees · USD

  • YTD
    −1.5%
    index +10.2%
  • 1Y
    +14.5%
    index +22.9%
  • 3Y · total
    +59.6%
    index +77.6%
  • 5Y · total
    +57.3%
    index +87.8%
  • Inception · total
    +101%
    index +210%

Index: S&P 500 (SPXTR)

Disclaimer

These figures are copied from the manager’s latest letter, as of Jun 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.

Read full disclosures →

What they bought and sold · 2 moves

  • September 2026
    “Few holdings were a meaningful drag on performance this quarter. The largest detractors were short-term hedges, using ETFs that track the S&P 500 (SPY) and the Nasdaq 100 (QQQ), which we opened and closed during the quarter.”
    Read the letter
  • September 2026
    “Few holdings were a meaningful drag on performance this quarter. The largest detractors were short-term hedges, using ETFs that track the S&P 500 (SPY) and the Nasdaq 100 (QQQ), which we opened and closed during the quarter.”
    Read the letter

Companies held · 5

Every company Leaven Partners has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 3

  • September 2026

    Hyakugo Bank benefits from rising Japanese interest rates and growth in deposits, loans, net income, and dividends.

    Read the full thesis
  • September 2026

    The Bank of Nagoya benefits from rising Japanese rates and an acquisition deal that supports the stock’s expected value.

    Read the full thesis
  • Manac Chemical Partners
    September 2026

    Manac Chemical Partners manufactures bromine-based chemicals and is showing strong turnaround momentum with higher sales, profits, margins, and dividends.

    Read the full thesis

Letter archive · 9

Get Leaven Partners’s next letter the day it lands

We track Leaven Partners alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans→
Share this fund